2020
The effects of augmenting clozapine with oxytocin in schizophrenia: An initial case series.
Marotta RF, Buono FD, Garakani A, Collins E, Cerrito B, David Rowe DR. The effects of augmenting clozapine with oxytocin in schizophrenia: An initial case series. Annals Of Clinical Psychiatry 2020, 32: 90-96. PMID: 32343282.Peer-Reviewed Case Reports and Technical NotesConceptsTreatment-resistant schizophreniaNegative symptomsAtypical antipsychoticsRetrospective chart reviewInitial case seriesAugmentation of clozapineChronic psychotic illnessNegative Syndrome ScaleYoung adult inpatientsSymptoms of schizophreniaParent/guardian reportsChart reviewCase seriesAdult inpatientsProspective studyAntipsychotic medicationClinical reviewTherapeutic responsePsychotic illnessTreatment approachesSyndrome ScalePositive symptomsTreating psychiatristSymptomsSustained treatment
2010
The Pharmacological Treatment of Bipolar Disorder: The Question of Modern Advances
Hirschowitz J, Kolevzon A, Garakani A. The Pharmacological Treatment of Bipolar Disorder: The Question of Modern Advances. Harvard Review Of Psychiatry 2010, 18: 266-278. PMID: 20825264, DOI: 10.3109/10673229.2010.507042.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsBipolar disorderGold standardMajor treatment guidelinesFirst-line treatmentMainstay of treatmentUse of lamotrigineTreatment of maniaBipolar maintenanceAtypical antipsychoticsTreatment guidelinesBipolar depressionMaintenance treatmentPharmacological treatmentFDA indicationMEDLINE searchNew agents